Профилактика И Коррекция Нейтропении И Анемии, Вызванных Противоопухолевой Химиотерапией

An overview of ASCO, ESMO, EORTC, ASH recommendations for prevention and therapy the chemotherapy-induced neutropenia and anemia is presented. Update of EORTC guidelines (2010) to reduce the incidence of chemotherapy-induced febrile neutropenia and the studies on which the update was made are described. Patient assessment algorithm to determine primary prophylactic G-CSF usage is presented. The usage of erythropoietins and intravenous iron for treatment of chemotherapy-induced anemia is described in detail. Review can help haematologists and oncologists to select an optimal way to prevent hematological complications of chemotherapy.